Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin's Lymphoma
- 1 October 2006
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 84 (3) , 242-247
Abstract
Late-onset grade 4 neutropenia occurred in 3 (5.6%) of 54 non-Hodgkin’s lymphoma patients treated with rituximab between September 2001 and March 2004. Neutropenia appeared 5 to 25 weeks after...Keywords
This publication has 20 references indexed in Scilit:
- B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasisBlood, 2005
- Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following SenescenceImmunity, 2003
- Delayed‐onset neutropenia associated with rituximab therapyBritish Journal of Haematology, 2003
- Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in JapanInternational Journal of Hematology, 2002
- Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2002
- Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two casesLeukemia Research, 2002
- Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphomaTransplantation and Cellular Therapy, 2000
- CD8+,CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: Implications for the neutropenia of Felty's and large granular lymphocyte syndromesArthritis & Rheumatism, 2000
- European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic LymphomaJournal of Clinical Oncology, 2000
- Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphomaAnnals of Oncology, 1999